维普中文期刊产品整合服务
33篇 您的检索式:作者名="Scalisi"
    题名 作者 年代 出处 被引量
1Novel endoscopic management for pancreatic pseudocyst with fistula to the common bile duct显示文摘Pancreatic pseudocyst formation is a well-known complication of pancreatitis. It represents about 75% of the cystic lesions of the pancreas and might be located within or surrounding the pancreatic tissue. Sixty percent of the occurrences resolve spontaneously and only persistent, symptomatic or complicated cysts need to be treated. Complications include infection, hemorrhage, gastric outlet obstruction, splenic infarction and rupture. The formation of fistulas to other viscera is rare and most commonly occurs within the stomach, duodenum or colon. We report a case of a patient with a pancreatic pseudocyst in communication with the common bile duct. There have been only few cases reported in the literature. We successfully managed our case by performing an endoscopicultrasound-guided drainage of the pancreatic collection and a contemporaneous stenting of the common bile duct. Performed independently, both drainages are effective, safe and well-coded and the expertise on these procedures is widespread. By our knowledge this therapeutic approach was never reported in literature but we retain this is the most correct treatment for this very rare condition.Stefano Francesco Crinò Giuseppe Scalisi Pierluigi Consolo Doriana Varvara Antonio Bottari Sebastiano Pantè Socrate Pallio 2014World Journal of Gastrointestinal Endoscopy2014,6,12:3
2Effectiveness of very low-volume preparation for colonoscopy:A prospective, multicenter observational study显示文摘BACKGROUND The effectiveness of colonoscopy strictly depends on adequate bowel cleansing.Recently,a 1 L polyethylene glycol plus ascorbate(PEG-ASC)solution(Plenvu;Norgine,Harefield,United Kingdom)has been introduced on the evidence of three phase-3 randomized controlled trials,but it had never been tested in the real-life.AIM To assess the effectiveness and tolerability of the 1 L preparation compared to 4 L and 2 L-PEG solutions in a real-life setting.METHODS All patients undergoing a screening or diagnostic colonoscopy after a 4,2 or 1 L PEG preparation,were consecutively enrolled in 5 Italian centers from September 2018 to February 2019.The primary endpoints of the study were the assessment of bowel cleansing success and high-quality cleansing of the right colon.The secondary endpoints were the evaluation of tolerability,adherence and safety of the different bowel preparations.Bowel cleansing was assessed through the Boston Bowel Preparation Scale.Adherence was defined as consumption of at least 75%of each dose,while tolerability was evaluated through a semiquantitative scale.Safety was systematically monitored through adverse events reporting.RESULTS Overall,1289 met the inclusion criteria and were enrolled in the study.Of these,490 patients performed a 4 L-PEG preparation(Selgesse^■),566 a 2 L-PEG cleansing(Moviprep^■or Clensia^■)and 233 a 1 L-PEG preparation(Plenvu^■).Bowel cleansing by Boston Bowel Preparation Scale was 6.5±1.5 overall and 6.3±1.5,6.2±1.5,7.3±1.5(P<0.001)in the subgroups of 4 L,2 L and 1 L-PEG preparation,respectively.Cleansing success was achieved in 72.4%,74.1%and 90.1%(P<0.001),while a high-quality cleansing of the right colon in 15.9%,12.0%and 41.4%(P<0.001)for 4 L,2 L and 1 L-PEG preparation groups,respectively.The 1 L preparation was the most tolerated compared to the 2 and 4 L-PEG solutions in the absence of serious adverse events within any of the three groups.Multiple regression models confirmed 1 L PEG-ASC preparation as an independent predictor of overall cleansing success,high-quality cleansing of the right colon and of tolerability.CONCLUSION This study supports the effectiveness and tolerability of 1 L PEG-ASC,also showing it is an independent predictor of overall cleansing success,high-quality cleansing of the right colon and of tolerability.Marcello Maida Emanuele Sinagra Gaetano Cristian Morreale Sandro Sferrazza Giuseppe Scalisi Dario Schillaci Marco Ventimiglia Fabio Salvatore Macaluso Giovanni Vettori Giuseppe Conoscenti Concetta Di Bartolo Serena Garufi Domenico Catarella Michele Manganaro Clara Maria Virgilio Salvatore Camilleri 2020World Journal of Gastroenterology2020,26,16:2
3Different characteristics of chronic heart falure(CHF) in elderly diabetics and nondiabetics显示文摘Romeo R Scalisi C Tafuri L 2010Arch Geron- tol Geriatr2010,50,:1
4Therapeutic options in osteoporo-sis显示文摘Dominguez LJ Scalisi R Barbagallo M 2010Acta Biomed2010,81,1:1
5Uterine cervical carcinoma: role of matrix metalloproteinases 显示文摘Libra M Scalisi A Vella N 2009Int J Oncol2009,34,4:1
6Different characteristcs of chornic heart falure(CHF)in elderly diabetics and non-diabetics显示文摘Romeo R Scalisi C Tafuri L 2010Arch Gerontol Geriatr2010,50,1:1
7Uterine cervical carcinoma:role of matrix metalloproteinases(review)显示文摘LIBRA M SCALISI A VELLA N 2009Int J Oncol2009,34,4:1
8Nonlinear optical activity in Ag-SiO2 nanocomposite thin films with different silver concentration 显示文摘Scalisi A A Compagnini G D'Urso L Puglisi O 2004Applied Surface Science2004,226,:1
9Nonlinear Optical Activity in Ag-SiO2 Nanocomposite Thin Films with Different Silver Concentration显示文摘Scalisi A A Compagnini G D' Urso L 2004Applied Surface Science2004,226,:1
10Giant secreting adrenal myeloli- poma in a man:a case report显示文摘Brogna A Scalisi G Ferrara R 2011J Med Case Rep2011,5,:1
11Therapeutic options in osteoporosis显示文摘Dominguez LJ Scalisi R Barbagal o M 0,,1:1
12Editorial comment to adrenal myelolipoma associated with hyperandrogenemia显示文摘Scalisi G 2012Int J Urol2012,19,11:1
13Organic Electronics显示文摘Scalisi R G Paleari M Favetto A 201518:892015,18,:1
14Therapeutic op- tions in os-teoporosis显示文摘Dominguez LJ Scalisi R Barbagallo M 2010Acta Biomed2010,81,1:1
15Thera- peutic options in osteoporosis 显示文摘DOMINGUEZ L J SCALISI R BARBAGALLO M 2010Aeta Biomed2010,81,4:1
16Uterine cervical carcinoma: role of matrix metalloproteinases显示文摘Libra M Scalisi A Vella N 2009Int J Oncol2009,34,4:1
17Editorial comment to adrenal myelolipoma associatedwith hyperandrogenemia 显示文摘Scalisi G 2012Int J Urol2012,19,11:1
18Different characteristics of chronic heart failure (CHF) in elderly diabetics and non- diabetics 显示文摘Romeo R Scalisi C Tafuri L 2010Arch Gerontol Geriatr2010,50,1:1
19Therapeutic options in osteoporosis 显示文摘Dominguez L J Scalisi R Barbagallo M 2010Acta Biomed2010,81,1:1
20Therapeutic options in osteoporosis显示文摘Dominguez LJ Scalisi R Barbagallo M 2010Acta Biomed2010,81,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费